Related references
Note: Only part of the references are listed.Minimizing Inappropriate Medications in Older Populations: A 10-step Conceptual Framework
Ian A. Scott et al.
AMERICAN JOURNAL OF MEDICINE (2012)
The Physics of Geriatric Pharmacotherapy: Overcoming Therapeutic Inertia and Momentum
Jerry H. Gurwitz
AMERICAN JOURNAL OF MEDICINE (2012)
Polypharmacy, Adverse Drug Reactions, and Geriatric Syndromes
Bhavik M. Shah et al.
CLINICS IN GERIATRIC MEDICINE (2012)
Prognostic Indices for Older Adults A Systematic Review
Lindsey C. Yourman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Guiding Principles for the Care of Older Adults with Multimorbidity: An Approach for Clinicians
Elvy Ickowicz
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
Donna Fick et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Informing Evidence-Based Decision-Making for Patients with Comorbidity: Availability of Necessary Information in Clinical Trials for Chronic Diseases
Cynthia M. Boyd et al.
PLOS ONE (2012)
Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect
Carlos O. Weiss et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria: Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT)
Frank P. Brouwers et al.
AMERICAN HEART JOURNAL (2011)
Principles of Conservative Prescribing
Gordon D. Schiff et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidity
Martin Fortin et al.
BMC FAMILY PRACTICE (2011)
STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation
P. Gallagher et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
Jorg Schilcher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Current Guidelines Have Limited Applicability to Patients with Comorbid Conditions: A Systematic Analysis of Evidence-Based Guidelines
Marjolein Lugtenberg et al.
PLOS ONE (2011)
The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review
Xin Sun et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Comparison of 80 versus 10 mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial)
John C. LaRosa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
Kenneth F. Schulz et al.
ANNALS OF INTERNAL MEDICINE (2010)
Feasibility Study of a Systematic Approach for Discontinuation of Multiple Medications in Older Adults Addressing Polypharmacy
Doron Garfinkel et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
The Challenge of Multiple Comorbidity for the US Health Care System
Anand K. Parekh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Managing Medications in Clinically Complex Elders There's Got to Be a Happy Medium
Michael A. Steinman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
An Analysis of the Interactions Between Individual Comorbidities and Their Treatments-Implications for Guidelines and Polypharmacy
Stephen P. Fitzgerald et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2010)
MENU LABELING: KNOWLEDGE FOR A HEALTHIER AMERICA
Tamara Schulman
HARVARD JOURNAL ON LEGISLATION (2010)
Medical Care for the Final Years of Life When You're 83, It's Not Going to Be 20 Years
David B. Reuben
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Vulnerable Elders-13 Survey Predicts 5-Year Functional Decline and Mortality Outcomes in Older Ambulatory Care Patients
Lillian Min et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
J. J. Brugts et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Antipsychotic-induced extrapyramidal symptoms and their management
Praveen Dayalu et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A framework for tailoring clinical guidelines to comorbidity at the point of care
R. Scott Braithwaite et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Quality indicators for medication use in vulnerable elders
William H. Shrank et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2007)
Frameworks for prescribing in comorbid illness
James P. Stevenson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
Efficacy and safe of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes - The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
Robert H. Knopp et al.
DIABETES CARE (2006)
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
Haruo Nakamura et al.
LANCET (2006)
Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases - Implications for pay for performance
CM Boyd et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia
ES Parris et al.
DIABETES CARE (2005)
Treating Individuals 2 - Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
PM Rothwell
LANCET (2005)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria
FW Asselbergs et al.
CIRCULATION (2004)
Managing comorbidities in patients at the end of life
J Stevenson et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Cancer screening in elderly patients - A framework for individualized decision making
LC Walter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)